Can Invenio Imaging’s AI deliver reliable lung biopsy feedback inside the bronchoscopy room?
Invenio Imaging completes ON-SITE enrolment as NIO Lung Cancer Reveal moves toward pivotal analysis and a potential FDA submission.
Invenio Imaging completes ON-SITE enrolment as NIO Lung Cancer Reveal moves toward pivotal analysis and a potential FDA submission.
Teal Health and UC Davis Health test how FDA-authorized at-home HPV screening can fit routine care and reach overdue patients.
Find out how Genentech’s Tecentriq Priority Review could reshape adjuvant treatment for stage III dMMR/MSI-H colon cancer.
A bladder cancer supply crisis meets fresh Phase III data. ImmunityBio’s Tokyo BCG deal could test how flexible U.S. regulators are willing to be.